BIOBANK LPCE-NICE CHEST
|
|
- Wendy Welch
- 8 years ago
- Views:
Transcription
1 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH N LB ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL
2 BIOBANK LE-NIE HEST athologist : M. ILIE 12/02/2013 Time for frozen procedure : 28 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 54 Sex : F ID : MO L Diagnosis and staging : squamous cell carcinoma grade 3 pt4n0 stage IIB Diagnosis of frozen specimens : squamous cell carcinoma Size : 7.5 cm Location : left upper lobe Weights : D1 : 107 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 117 mg, R2 : 111 mg, R3 : 91 mg, R4 : 70 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : left upper lobe Histology : mild alveolitis 2D- Specimens for diagnosis : Weights : D1 : 200 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 180 mg, R2 : 180 mg, R3 : 90 mg, R4 : 129 mg 4- ontrols of quality x1000µL erilesion
3 BIOBANK LE-NIE HEST athologist :. BUTORI 12/03/2013 LE / HU Unit atient : LH N LB ID : DE JE onsent : YES Age : 64 Diagnosis and staging : ISET 1257 Old tuberculosis and squamous cell carcinoma 3x1000µL
4 BIOBANK LE-NIE HEST athologist :. BUTORI 12/03/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 48 ID : BL DI Diagnosis and staging : adipous tissu Diagnosis of frozen specimens : adipous tissu Size : 3 x 2 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 196 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 312 mg, R2 : 352 mg 4- ontrols of quality Not available erilesion
5 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/04/2013 Time for frozen procedure : 16 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 63 ID : TO NO Diagnosis and staging : biphasic mesothelioma lung metastasis (vaginal testis) Diagnosis of frozen specimens : biphasic mesothelioma Size : 2 cm Location : lingula Weights : D1 : 18 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 16 mg, R2 : 25 mg, R3 : 13 mg, R4 : 9 mg ercent of tumor cells : 90 % 2- erilesional tissue specimens Location : lingula Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 34 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 18 mg, R2 : 21 mg, R3 : 12 mg, R4 : 23 mg 4- ontrols of quality 4x1000µl erilesion
6 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/04/2013 Time for frozen procedure : 14 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 74 Sex : F ID : I LI Diagnosis and staging : siewert type 1 adenocarcinoma of the oesophagus post chemotherapy pt3n1 Diagnosis of frozen specimens : grade 2 adenocarcinoma Size : 3 x 2.5 cm Location : oesogastric jonction Weights : D1 : 38 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 50 mg, R2 : 45 mg, R3 : 56 mg, R4 : 25 mg ercent of tumor cells : 60 % 2- erilesional tissue specimens Location : lower oesophagus Histology : normal mucosis 2D- Specimens for diagnosis : Weights : D1 : 29 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 42 mg, R2 : 40 mg, R3 : 35 mg, R4 : 40 mg 4- ontrols of quality erilesion
7 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 06/12/2013 Time for frozen procedure : 8 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 60 Sex : F ID : AM MA Diagnosis and staging : metastatic (lymph node) lung neuroendocrine small cell carcinoma (ptxn2mx) Diagnosis of frozen specimens : neuroendocrine small cell carcinoma Size : 0.5 cm Location : site 7 2- erilesional tissue specimens None Weights : D1 : 47 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 31 mg ercent of tumor cells : 20 % 4- ontrols of quality Not available erilesion
8 BIOBANK LE-NIE HEST LE / HU Unit athologist : E. LONG-MIRA 12/06/2013 lamp : 15 mn ; Frozen procedure : 48 mn ; T : 63 mn atient : N LH N LB onsent : NO Age : 61 ID : O MA Diagnosis and staging : mild differentiated squamous cell carcinoma (pt3n1mx) Diagnosis of frozen specimens : inflammatory fibrosis, no tumor cell Size : 15 x 6 cm Location : left lower lobe Weights : D1 : 152 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 132 mg, R2 : 182 mg, R3 : 129 mg, R4 : 128 mg ercent of tumor cells : 0 % 2- erilesional tissue specimens Location : left lower lobe Histology : alveolitis 2D- Specimens for diagnosis : Weights : D1 : 58 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 220 mg, R2 : 175 mg, R3 : 108 mg, R4 : 73 mg 4- ontrols of quality 2x1000µL erilesion
9 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 67 Sex : F ID : MA DA Diagnosis and staging : type B3 thymoma largely invasive with pleuro diaphragmatic implants Diagnosis of frozen specimens : type B3 thymoma Size : 4.5 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 124 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 118 mg, R2 : 144 mg, R3 : 88 mg, R4 : 120 mg ercent of tumor cells : 70 % 4- ontrols of quality Not available 3x1000µL erilesion
10 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 Time for frozen procedure : 8 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : ES JA Diagnosis and staging : lung adenocarcinoma lymph node metastasis Diagnosis of frozen specimens : solid adenocarcinoma with mucinous secretion Size : 0.6 cm Location : right site 2 2- erilesional tissue specimens None Weights : D1 : 21.5 mg ercent of tumor cells : 60 % 4- ontrols of quality For diagnosis bank : YES L1 (tube D1): : 0,20445 µg/µl ; Tot qty: 34.9 µg DO 260/ ; R pyro EGFR : OK Biobank - LM Not available erilesion
11 BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : LH N LB ID : MA DO onsent : YES Age : 57 Diagnosis and staging : ISET 1266 ost traumatic necrosis, no tumor 1x1000µL
12 BIOBANK LE-NIE HEST LE / HU Unit athologist : V. HOFMAN 12/10/2013 lamp : 10 mn ; Frozen procedure : 30 mn ; T : 40 mn atient : N LH N LB onsent : NO Age : 66 Sex : F ID : DE H Diagnosis and staging : grade 2 adenocarcinoma acinous predominant with papillary component pt1bnx and second adenocarcinoma with minimal invasion of the left lower lobe pt1a Diagnosis of frozen specimens : adenocarcinoma acinous predominant Size : 2.5 x 2 cm Location : left upper lobe Weights : D1 : 85 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 92 mg, R2 : 123 mg, R3 : 49 mg ercent of tumor cells : 40 % 2- erilesional tissue specimens Location : left upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 75 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 60 mg, R2 : 77 mg, R3 : 79 mg, R4 : 84 mg 4- ontrols of quality For diagnosis bank : YES 2x1000µL erilesion
13 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/10/2013 Time for frozen procedure : 60 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 58 Sex : F ID : DA TH Diagnosis and staging : nodular tuberculosis probably Diagnosis of frozen specimens : nodular tuberculosis Size : 2 cm Location : left lower lobe Weights : D1 : 25 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 26 mg, R2 : 23 mg, R3 : 15 mg, R4 : 18 mg 2- erilesional tissue specimens Location : left lower lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 12 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 18 mg, R2 : 15 mg, R3 : 22 mg, R4 : 24 mg 4- ontrols of quality Infection : YES (tuberculosis) erilesion
14 BIOBANK LE-NIE HEST athologist : M. ILIE 12/11/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 ID : TE H Diagnosis and staging : undifferentiated malignant tumor with spindle cells (p63+, Vim+, WT1+). Diagnosis of frozen specimens : undifferentiated malignant tumor (mesopath : malignant inclassed tumor, sarcomatoid carcinoma? Size : 1 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 35 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 23 mg, R2 : 49 mg, R3 : 44 mg ercent of tumor cells : 85 % 4- ontrols of quality Not available 2x1000µL erilesion
15 BIOBANK LE-NIE HEST LE / HU Unit athologist : M. ILIE 12/11/2013 lamp : 8 mn ; Frozen procedure : 27 mn ; T : 35 mn atient : N LH N LB onsent : YES Age : 78 Sex : F ID : BR AL Diagnosis and staging : mucinous adenocarcinoma with solid, «signet-ring», micropapillary component pt2an0mx (IIB) Diagnosis of frozen specimens : mucinous adenocarcinoma Size : 3 cm Location : right lower lobe Weights : D1 : 78 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 110 mg, R2 : 82 mg, R3 : 45 mg, R4 : 90 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : right lower lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 250 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 180 mg, R2 : 167 mg, R3 : 243 mg, R4 : 144 mg 4- ontrols of quality For diagnosis bank : YES 2x1000µL erilesion
16 BIOBANK LE-NIE HEST LE / HU Unit athologist : M. ILIE 12/11/2013 lamp : 15 mn ; Frozen procedure : 60 mn ; T : 75 mn atient : N LH N LB onsent : YES Age : 70 Sex : F ID : MI MA Diagnosis and staging : atypical carcinoid pt1an1 Diagnosis of frozen specimens : atypical carcinoid Size : 1.7 cm Location : left upper lobe Weights : D1 : 121 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 110 mg, R2 : 160 mg 2- erilesional tissue specimens Location : left upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 139 mg 2R- Specimens for research : Nb : 2 Weights : R1 : 180 mg, R2 : 160 mg ercent of tumor cells : 70 % 4- ontrols of quality 3 x1000µl erilesion
17 BIOBANK LE-NIE HEST athologist : M. ILIE 12/11/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 79 ID : BO JO Diagnosis and staging : mucinous acinous adenocarcinoma grade 3 pt3n0mx (IIB) Diagnosis of frozen specimens : mucinous acinous adenocarcinoma Size : 5.5 x 4.5 x 4 cm Location : right upper lobe Weights : D1 : 68 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 44 mg, R2 : 83 mg, R3 : 105 mg, R4 : 34 mg ercent of tumor cells : 80 % 2- erilesional tissue specimens Location : right upper lobe Histology : moderate emphysema 2D- Specimens for diagnosis : Weights : D1 : 150 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 70 mg, R2 : 83 mg, R3 : 113 mg, R4 : 75 mg 4- ontrols of quality L(1) (tube D1): : 0,16374 µg/µl ; Tot qty: 27,2 µg DO 260/ ; R pyro EGFR : OK L(2) (tube D1): : 0,09577 µg/µl ; Tot qty: 18.8 µg DO 260/ ; R pyro KRAS : OK Biobank - LM erilesion
18 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/12/2013 LE / HU Unit atient : N LH N LB onsent : NO Age : 44 ID : SI H Diagnosis and staging : leiomyosarcoma lung metastasis Sex : F For diagnosis bank : YES 2 x 1000 µl 1 x 500 µl
19 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/12/2013 LE / HU Unit atient : N LH N LB onsent : YES Age : 75 ID : NI JE Diagnosis and staging : acinar predominant adenocarcinoma, pt2an2 Infection : unknown For diagnosis bank : YES 3x1000µl
20 BIOBANK LE-NIE HEST athologist : M. ILIE 12/13/2013 LE / HU Unit atient : N LH N LB onsent : NO Age : 34 ID : DE LA Diagnosis and staging : site 7 lymph node with acidophil ischemic necrosis without granuloma (no etiology) Sex : F 2x1000µL
21 BIOBANK LE-NIE HEST athologist : M. ILIE 12/13/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 57 ID : BO HO Diagnosis and staging : lung adenocarcinoma pleural metastasis Diagnosis of frozen specimens : lung adenocarcinoma pleural metastasis Size : 1.5 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 52 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 30 mg, R2 : 31 mg ercent of tumor cells : 20 % 4- ontrols of quality For diagnosis bank : YES Not available 1x1000µL erilesion
22 BIOBANK LE-NIE HEST athologiste :. BUTORI 16/12/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 66 Sex : F ID : JU MA Diagnosis and staging : (probably breast) sarcomatoid carcinoma parietal metastasis Diagnosis of frozen specimens : sarcomatoid carcinoma Size : 3 cm Location : chest parietal 2- erilesional tissue specimens None Weights : D1 : 172 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 143 mg, R2 : 139 mg, R3 : 191 mg, R4 : 115 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available 4x1000µL erilesion
23 BIOBANK LE-NIE HEST athologist :. BUTORI 12/16/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 63 Sex : F ID : DA MI Diagnosis and staging : mediastinal schwannoma Diagnosis of frozen specimens : schwannoma Size : 2.8 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 225 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 195 mg, R2 : 172 mg, R3 : 127 mg, R4 : 139 mg ercent of tumor cells : 80 % 4- ontrols of quality For diagnosis bank : YES Not available 1x1000µL erilesion
24 BIOBANK LE-NIE HEST athologist :. BUTORI 12/16/2013 Time for frozen procedure : 6 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 75 ID : LA I Diagnosis and staging : encapsulated type A thymoma Diagnosis of frozen specimens : type A thymoma Size : 2 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 83 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 82 mg, R2 : 23 mg ercent of tumor cells : 80 % 4- ontrols of quality Not available erilesion
25 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/17/2013 Time for frozen procedure : 35 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 58 Sex : F ID : NO AN Diagnosis and staging : large cell carcinoma pt1an0 Diagnosis of frozen specimens : large cell carcinoma Size : 2 cm Location : Nelson Weights : D1 : 24 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 36 mg, R2 : 38 mg, R3 : 32 mg, R4 : 38 mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : Nelson Histology : respiratory bronchiolitis 2D- Specimens for diagnosis : Weights : D1 : 74 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 40 mg, R2 : 40 mg, R3 : 71 mg, R4 : 67 mg 4- ontrols of quality 3x 1000µL erilesion
26 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/17/2013 Time for frozen procedure : 25 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 ID : RE MA Diagnosis and staging : malignant solitary fibrous pleural tumor Diagnosis of frozen specimens : malignant solitary fibrous pleural tumor Size : 25 cm Location : right pleura 2- erilesional tissue specimens None Weights : D1 : 94 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 122 mg, R2 : 144 mg, R3 : 170 mg, R4 : 120 mg ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES Not available 1 x1000µl erilesion
27 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 72 ID : LE JE Diagnosis and staging : metastatic melanoma Diagnosis of frozen specimens : metastatic melanoma Size : 2 x 1.7 cm Location : lingula Weights : D1 : 61 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 58 mg, R2 : 38 mg, R3 : 35 mg, R4 : 37 mg ercent of tumor cells : 90 % 2- erilesional tissue specimens Location : lingula Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 51 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 51 mg, R2 : 44 mg, R3 : 28 mg, R4 : 35 mg 4- ontrols of quality L1 (tube D1): : 0,24348 µg/µl ; Tot qty: 43,2 µg DO 260/280: 2,02 ; R pyro EGFR : OK Biobank - LM 3x1000µL erilesion
28 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 16 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 Sex : F ID : I GE Diagnosis and staging : acinous and papillary invasive adenocarcinoma (pt1an0mx) Diagnosis of frozen specimens : acinous and papillary adenocarcinoma Size : 1.5 x 1 cm Location : left upper lobe Weights : D1 : 27 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 12 mg 2- erilesional tissue specimens Location : left upper lobe Histology : adenocarcinoma (10 %) 2D- Specimens for diagnosis : Weights : D1 : 92 mg 2R- Specimens for research : Nb : 1 Weights : R1 : 77 mg ercent of tumor cells : 50 % 4- ontrols of quality For diagnosis bank : YES erilesion
29 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/13/2013 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 70 ID : DE HE Diagnosis and staging : large cell carcinoma lymph node metastasis Diagnosis of frozen specimens : large cell carcinoma (epidermoid ) Size : 0.3 to 0.7 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 71 mg 1R- Specimens for research : Nb : 1 Weights : R1 : 70 mg ercent of tumor cells : 60 % 4- ontrols of quality Not available erilesion
30 BIOBANK LE-NIE HEST athologist : E. LONG-MIRA 12/18/2013 Time for frozen procedure : 30 mn LE / HU Unit atient : N LH N LB onsent : Refusal of consent ID : AD E Age : 45 Sex : F Diagnosis and staging : metastatic lung adenocarcinoma (lymph node) ptxn3mx Diagnosis of frozen specimens : metastatic Lung adenocracinoma Size : 1.6 cm Location : sus clavicular lymph node Weights : D1 : 105 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 39 mg, R2 : 52 mg, R3 : 51 mg 2- erilesional tissue specimens None ercent of tumor cells : 20 % 4- ontrols of quality Infection : YES (HIV) For diagnosis bank : YES L1 (tube D1): : 0,19391 µg/µl ; Tot qty: 32.8 µg DO 260/280: 1,97 ; R pyro EGFR : OK Not available Biobank - LM erilesion
31 BIOBANK LE-NIE HEST athologist : V. HOFMAN 12/19/2013 LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : ME GE Diagnosis and staging : lung adenocarcinoma, acinar predominant (grade 3), pt1an1 For diagnosis bank : YES 3x1000µL
32 BIOBANK LE-NIE HEST athologist : M. ILIE 12/18/2013 Time for frozen procedure : 5 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 61 ID : BE JE Diagnosis and staging : small cell neuroendocrin carcinoma lymph node metastasis Diagnosis of frozen specimens : small cell neuroendocrin carcinoma Size : 1 cm Location : lymph node site 4 2- erilesional tissue specimens None Weights : D1 : 105 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 74 mg, R2 : 90 mg, R3 : 84 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available 2x1000µL erilesion
33 BIOBANK LE-NIE HEST LE / HU Unit athologist : S. LASSALLE 12/23/2013 lamp : 15 mn ; Frozen procedure : 140 mn ; T : 155 mn atient : N LH N LB onsent : YES Age : 50 ID : BA H Diagnosis and staging : squamous cell carcinoma (grade 2), ypt2an1 Diagnosis of frozen specimens : squamous cell carcinoma Size : 5 cm Location : right lobe Weights : D1 : 46 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 67 mg, R2 : 66 mg, R3 : 60 mg 2- erilesional tissue specimens Location : right lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 124 mg 2R- Specimens for research : Nb : 3 Weights : R1 : 103 mg, R2 : 104 mg, R3 : 72 mg ercent of tumor cells : 60 % 4- ontrols of quality Infection : Unknown 4 x1000µl erilesion
34 BIOBANK LE-NIE HEST athologist : S. LASSALLE 12/23/2013 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 57 Sex : F ID : GO IR Diagnosis and staging : lung adenocarcinoma pleural metastasis Diagnosis of frozen specimens : adenocarcinoma Location : pleura Weights : D1 : 24 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 21 mg, R2 : 28 mg 2- erilesional tissue specimens None ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES L (tube D1): : 0,13027 µg/µl ; Tot qty: 22.8 µg DO 260/ ; R pyro EGFR : OK BioBank - LM Not available erilesion
35 BIOBANK LE-NIE HEST LE / HU Unit athologist :. BUTORI 12/30/2013 lamp : 30 mn ; Frozen procedure : 15 mn ; T : 45 mn atient : N LH N LB onsent : YES Age : 33 Sex : F ID : L MA Diagnosis and staging : undifferentiated carcinoma lung metastasis Diagnosis of frozen specimens : thyroid undifferentiated carcinoma Size : 1.8 cm Location : right upper lobe Weights : D1 : 63 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 65 mg, R2 : 78 mg, R3 : 80 mg, R4 : 80 mg ercent of tumor cells : 90% (need to be verified) 2- erilesional tissue specimens Location : right upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 185 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 200 mg, R2 : 169 mg, R3 : 127 mg, R4 : 109 mg 4- ontrols of quality (tube D1): - : 0,23370µg/µl ; Tot qty: 41,6 µg -DO 260/280: 1,99 Biobank BS F.edeutour 3 x 1000 µl erilesion
36 BIOBANK LE-NIE HEST athologist :. BUTORI 12/30/2013 Time for frozen procedure : 37 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 30 Sex : F ID : VE AU Diagnosis and staging : typic carcinoid tumor pt1an0 Diagnosis of frozen specimens : typic carcinoid tumor Size : 2 cm Location : left lower lobe Weights : D1 : 30 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 40 mg, R2 : 87 mg, R3 : 26 mg, R4 : 30 mg ercent of tumor cells : 70 % 2- erilesional tissue specimens Location : distal Histology : broncho pneumonia 2D- Specimens for diagnosis : Weights : D1 : 77 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 46 mg, R2 : 89 mg, R3 : 100 mg, R4 : 53 mg 4- ontrols of quality 2 x 1000 µl erilesion
37 BIOBANK LE-NIE HEST athologist :. BUTORI 12/30/2013 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 76 ID : O SE Diagnosis and staging : malignant epithelioid mesothelioma Stage IV Diagnosis of frozen specimens : malignant epithelioid mesothelioma Size : 1 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 123 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 128 mg, R2 : 131 mg, R3 : 126 mg, R4 : 140 mg ercent of tumor cells : 80 % 4- ontrols of quality Not available 3 x 1000 µl erilesion
BIOBANK LPCE-NICE CHEST
BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/03/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH 11-0004 N LB 11-0002 onsent : YES Age : 37 ID : TH ER Diagnosis and staging : Hodgkin
More informationBIOBANK LPCE-NICE CHEST
HEST athologist :. BUTORI 08/01/2012 Time for frozen procedure : 45 mn LE / HU Unit atient : N LH 12-2304 N LB 12-0337 onsent : YES Age : 62 ID : MA H Diagnosis and staging : lung adenocarcinoma lymph
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationPathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
More informationYOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
More informationLung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine
Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
More informationPrimary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
More informationRare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
More informationINFLAMMATORY PLEURAL EFFUSION
PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary
More informationNeoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
More informationDiagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
More informationINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
More informationLung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology
Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists
More informationThe Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
More informationThe develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
More informationDiseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours
Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains
More informationRecommendations for the Reporting of Pleural Mesothelioma
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
More informationPATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
More informationObjectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
More informationIndex. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin
A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,
More informationPlueral Malignancy: Radiologic-pathologic
Plueral Malignancy: Radiologic-pathologic Correlation Ritu R. Gill, MD Pleural Malignancies: Radiologic-Pathologic Correlation Ritu R Gill MD Brigham and Women s Hospital Boston, Massachusetts Pleural
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationMale. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
More informationExtrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
More informationAcadémie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
More informationCASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital
More informationLung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
More informationImmunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
More informationDiagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
More informationA 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
More informationPleural and Chest Wall Tumors
Pleural and Chest Wall Tumors Ritu Gill, MD, MPH Dr. Ritu R. Gill Department t of Radiology Brigham and Women s Hospital Harvard Medical School CLASSIFICATION OF CHEST WALL TUMORS Primary neoplasm of chest
More informationCHAPTER 3: LUNG CANCER OVERVIEW
CHAPTER 3: LUNG CANCER OVERVIEW INTRODUCTION Learning about lung cancer is an important part of preparing for the decisions you will be making about your treatment and aftercare. The more you know about
More informationIII II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access
UUID : 10F97F63 - EE6F-448D - 98E1-8AAA21F55753 TCGA - TS-A7PB-01A-PR Redacted III II II 111111111111111111111111111111111111111111 1 1111111111111 III Date Receive III 11111111111111111 11111111111 II
More informationEfficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach
Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society
More informationContents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12
Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background
More informationGeneral Information About Non-Small Cell Lung Cancer
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
More informationHow To Diagnose And Treat A Tumour In An Effusion
Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura
More informationCase based applications part III
Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.
More informationLessons from a consultation practice
Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter
More informationTUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short
More informationCase Report Predominantly Fibrous Malignant Mesothelioma in a Cat
SAGE-Hindawi Access to Research Volume 2010, Article ID 396794, 4 pages doi:10.4061/2010/396794 Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat Alexander Th. A. Weiss, Afonso B. da Costa,
More informationOvarian tumors Ancillary methods
Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of
More informationAbout lung cancer. Contents. The lungs
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 7. The lungs Contents The lungs Types of lung cancer
More informationThis factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.
There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers
More informationThe National Clinical Lung Cancer Audit (LUCADA)
The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name
More informationOncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver
Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.
More informationCardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
More informationIntroduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationPleural and Pericardial fluids a one year analysis
Pleural and Pericardial fluids a one year analysis Dr Olafsdottir Dr J Williams Department of Cytology, Llandough Hospital Contents Background Standards Aims/Questions Investigation group Results Conclusions
More informationGeneral Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationGeneral Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung
ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle
More informationPOLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationSummary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
More informationMalignant Mesothelioma Diagnosed by Bronchoscopic Biopsy
CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,
More informationMore than 2,500 people are diagnosed with mesothelioma in the UK each year.
This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal
More informationASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
More informationCytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%
More information3-F. Pathology of Mesothelioma
3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which
More informationHow To Write Lung Cancer Data Standards For Nhs Scotland
For reference only Do Not Use For more information contact: cdsis@nhs.net Lung Cancer Pathology Data Standards June 2008 National Clinical Dataset Development Programme (NCDDP) Support Team Information
More informationMultiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
More informationR-16: Chronic nonspecific cervisit
R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium
More informationFrozen Section Diagnosis
Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The
More informationMODERN IMMUNOHISTOCHEMISTRY
MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,
More informationTherapy of pleural effusions Modern techniques
Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate
More informationLUNG CANCER. FCDS 2011 Educational Webcast Series November 17, 2011
LUNG CANCER FCDS 2011 Educational Webcast Series November 17, 2011 Judy Bonner, RN, MS, CTR and Lynne Pearson, CTR, LHRM Steven Peace, CTR Updated for 2011 Requirements and CSv02.03.02 1 Presentation Outline
More informationA. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.
5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen
More informationP R E F E I T U R A M U N I C I P A L D E J A R D I M
D E P A R T A M E N T O D E C O M P R A S E L I C I T A O A U T O R I Z A O P A R A R E A L I Z A O D E C E R T A M E L I C I T A T с R I O M O D A L I D A D E P R E G O P R E S E N C I A L N 034/ 2 0
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationNotice of Faculty Disclosure
The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with
More informationDIFFICULTIES IN THE PATHOLOGIC DIAGNOSIS OF LUNG CANCER Notice of Financial Disclosures (TV Colby MD) (Esp. in small biopsies) Personal Experience Thomas V. Colby, M.D. Mayo Clinic Arizona NONE This talk
More informationProtocol for the Examination of Specimens From Patients With Tumors of the Peritoneum
Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors and malignant mesothelial neoplasms of the
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationTHE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses
Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce
More informationThoracic Cavity. Photo: This normal canine lung collapsed when the thorax was opened and the negative pressure was lost in the thorax.
Thoracic Cavity There are significant anatomical differences in the mediastinum of domestic animals. For instance, bovines, like humans, have well-developed mediastinal separation between the left and
More informationCytopathology Case Presentation #8
Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents
More informationUnderstanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
More informationMalignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge
Iran J Radiol. 2016 January; 13(1): e10949. Published online 2015 November 14. CHEST IMAGING DOI: 10.5812/iranjradiol.10949 Research Article Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura:
More informationSurgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND
Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis
More informationPROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
More informationBiphasic pericardial and pleural mesothelioma in a cat: a case report
Veterinarni Medicina, 60, 2015 (2): 105 108 Case Report Biphasic pericardial and pleural mesothelioma in a cat: a case report S.J. Gabriel Filho 1, G.M. Magalhaes 2, V.A. Conforti 2, J. Santilli 2, S.G.
More informationFNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.
Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters:
More informationJ of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
More informationTreatment of mesothelioma in Bloemfontein, South Africa
European Journal of Cardio-thoracic Surgery 24 (2003) 434 440 www.elsevier.com/locate/ejcts Treatment of mesothelioma in Bloemfontein, South Africa W.J. de Vries*, M.A. Long Cardiothoracic Department,
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationDELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
More informationUnderstanding your pathology report
Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What
More informationHow To Know When To Stage Lung Cancer
WHITE PAPER - SBRT for Non Small Cell Lung Cancer I. Introduction This white paper will focus on non-small cell lung carcinoma with sections one though six comprising a general review of lung cancer from
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationAsthma - morphology ARDS. Acute restrictive lung disease. Diffuse pulmonary diseases. Pulmonary fibrosis, asbestosis and mesothelioma
Diffuse pulmonary diseases Pulmonary fibrosis, asbestosis and mesothelioma 2012 by MB Obstructive Limitation of air flow, resulting from obstruction at any level (asthma airway narrowing; emphysema loss
More informationWhat is Mesothelioma?
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
More informationBrigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA
Determination of Biomarker Response in a Phase II Window of Opportunity Study of Defactinib (VS 6063), a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Resectable Malignant Pleural Mesothelioma
More informationSCD Case Study. Most malignant lesions of the tonsil are either lymphosarcoma or carcinoma.
SCD Case Study Dry Mouth This case study details a patient who has experienced xerostomia as a result of treatment for squamous cell carcinoma of the left tonsil involving surgery followed by deep x-ray
More informationRenal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD
Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic
More information